ABSTRACT
Elemicin (Ele) is a constituent of natural alkenylbenzene present in many foods and herbs. Ele exposure could induce hepatomegaly and hepatosteatosis. However, the role of gut microbiota in Ele-induced hepatotoxicity remains unclear. Here, the mice were treated with 200 mg/kg/day of Ele for 4 weeks with or without depletion of gut microbiota by antibiotics cocktail treatment. The mice treated with Ele showed enlargement of liver and slight hepatosteatosis, accompanied by higher levels of serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), triglyceride (TG). Ele could also shift the structure of fecal microbiota and increase the richness. Functional prediction of the microbiota revealed the enrichment of non-alcoholic fatty liver disease pathway upon Ele exposure. Compared with control group, Patescibacteria and Epsilonbacteraeota were significantly enriched at the phylum level upon Ele treatment. A total of 20 genera were significant with respect specifically to Ele exposure, including decreased Alistipes and elevated Ruminiclostridium_9 and Gordonibacter. Among them, 13 retained significant associations with ALT and TG by Spearman correlation test, 4 were correlated with AST. Further MaAsLin analysis revealed that ALT was associated with 4 differentially abundant genera, such as Alistipes and Ruminiclostridium_9 and Gordonibacter. In addition, only Alistipes was significantly correlated with serum TG. Intriguingly, depletion of the microbiota significantly attenuated hepatosteatosis, restore increased ALT, AST and TG and inhibit the expression of genes involved in de novo lipogenesis and adipocyte differentiation, such as Fasn, ADIPOQ and leptin. Collectively, depletion of gut microbiota protected against Ele induced aberrant lipid metabolism in mice.
Subject(s)
Bacteria/drug effects , Chemical and Drug Induced Liver Injury/etiology , Fatty Liver/chemically induced , Gastrointestinal Microbiome/drug effects , Hepatomegaly/chemically induced , Lipid Metabolism/drug effects , Liver/drug effects , Pyrogallol/analogs & derivatives , Alanine Transaminase/blood , Animals , Aspartate Aminotransferases/blood , Bacteria/growth & development , Bacteria/metabolism , Biomarkers/blood , Chemical and Drug Induced Liver Injury/metabolism , Chemical and Drug Induced Liver Injury/microbiology , Chemical and Drug Induced Liver Injury/pathology , Dysbiosis , Fatty Liver/metabolism , Fatty Liver/microbiology , Fatty Liver/pathology , Hepatomegaly/metabolism , Hepatomegaly/microbiology , Hepatomegaly/pathology , Liver/metabolism , Liver/pathology , Mice, Inbred C57BL , Pyrogallol/toxicity , Triglycerides/bloodABSTRACT
Paracoccidioidomycosis (Pm) is a systemic disease, endemic in the American continent. There are two different clinical forms, the infant-juvenile or subacute form (PmS) and the chronic adult form (PmC). The human immunodeficiency virus (HIV) associated paracoccidioidomycosis (PmHIV) shares characteristics with both of the previously mentioned forms. The objective of this work was to describe the epidemiological, clinical and laboratory features of the PmHIV and to compare them with the ones of PmS and the PmC. A retrospective analysis of 119 patients with paracoccidioidomycosis was performed. Ninety four suffered the chronic form, 11 the subacute one and 14 were coinfected with HIV. Patients with PmHIV presented a CD4+ T lymphocytes median of 70.5 cells/µl, 71.4% had fever, 64.3% had a miliary pattern on the chest radiography, 64.3% had hepatosplenomegaly, 64.3% had mucosal lesions and 50% had skin lesions. One patient died during his hospitalization. The clinical presentation of Pm in patients with HIV resembled the subacute form with fever, hepatomegaly and skin lesions. However, they also tended to present mucosal lesions, positive serology for Pm and pulmonary parenchyma lesions as usually seen in PmC (9/14 PmHIV patients had overlapping features, while 4/14 PmHIV patients clinically resembled PmS and 1/14 PmC). The incidence of Pm has not changed with the burden of AIDS as it has happened with other fungal infections but it appears clinically different from the classic clinical forms of the disease.
Subject(s)
Acquired Immunodeficiency Syndrome/complications , Acquired Immunodeficiency Syndrome/microbiology , Paracoccidioidomycosis/microbiology , Adult , Antifungal Agents/therapeutic use , Argentina/epidemiology , CD4-Positive T-Lymphocytes , Female , Fever/microbiology , HIV Infections/microbiology , Hepatomegaly/microbiology , Humans , Incidence , Male , Middle Aged , Paracoccidioidomycosis/drug therapy , Paracoccidioidomycosis/epidemiology , Radiography , Retrospective Studies , Thorax/diagnostic imaging , Thorax/microbiologyABSTRACT
MEDICAL HISTORY AND INITIAL PRESENTATION: A 35-year-old patient with a previous history of persistent episodic fever, sore throat, myalgia, and cephalgia presented for evaluation of pancytopenia. He had no recent travel history, except for a stay in Italy 1 year prior to admission and in Spain several years in the past. DIAGNOSTIC WORKUP: Laboratory evaluation confirmed pancytopenia, agranulocytosis, and elevated infection parameters without indicative serological results en par with lymphadenitis colli. Computed tomography scanning revealed cervical lymphadenopathy, hepatosplenomegaly, and colitis with occult perforation of the sigmoid colon. Bone marrow biopsy showed an infiltration of polyclonal plasma cells. Lymph node biopsy was compatible with necrotizing lymphadenitis. DIAGNOSIS: Polymerase chain reaction analysis of a lymph node specimen confirmed the presence of Leishmania species, thereby enabling the diagnosis of visceral Leishmania. THERAPY COURSE: Treatment with liposomal amphotericin B was initiated. Both fever and lymphadenopathy quickly resolved. CONCLUSION: VL is a clinically pleiotropic, severe disease with fatal outcome if left untreated. It often presents with distinct similarities to hematologic malignancies. Exacerbation can occasionally occur as fulminant macrophage activation syndrome. Disease incidence is globally increasing and has not peaked as yet. A complex interplay between pathogen and the immune system is the key pathophysiological mechanism.
Subject(s)
Fever/etiology , Leishmania donovani/isolation & purification , Leishmaniasis, Visceral/diagnosis , Pancytopenia/etiology , Adult , Amphotericin B/administration & dosage , Amphotericin B/therapeutic use , Antiprotozoal Agents/administration & dosage , Antiprotozoal Agents/therapeutic use , Diagnosis, Differential , Hepatomegaly/diagnostic imaging , Hepatomegaly/drug therapy , Hepatomegaly/microbiology , Humans , Leishmania donovani/genetics , Leishmaniasis, Visceral/drug therapy , Liposomes , Male , Pancytopenia/diagnosis , Splenomegaly/diagnostic imaging , Splenomegaly/drug therapy , Splenomegaly/microbiology , Tomography, X-Ray Computed , Treatment OutcomeABSTRACT
We present the case of a patient who sought treatment for fever and a maculopapular rash involving the trunk, limbs, palms and soles. The patient also presented with hepatomegaly and elevated levels of liver enzymes (with a higher increase of alkaline phosphatase). With the proposal of early syphilitic hepatitis, during the stage of secondary syphilis, a venereal disease research laboratory and Treponema pallidum haemagglutination tests were requested, which confirmed the diagnosis. All altered parameters improved with antibiotic treatment for secondary syphilis. Syphilitic hepatitis is an often overlooked presentation of syphilis and should be considered as a differential diagnosis in patients with elevated levels of liver enzymes and risk factors for syphilis.
Subject(s)
Hepatitis/etiology , Syphilis/complications , Anti-Bacterial Agents/therapeutic use , Diagnosis, Differential , Exanthema , Female , Hepatitis/microbiology , Hepatomegaly/etiology , Hepatomegaly/microbiology , Humans , Syphilis/drug therapyABSTRACT
Histoplasma microconidia when inhaled are presented in antigenic form to T cells, limiting the extent of infection; however, defects in cellular immunity results in disseminated disease. Chronic lymphocytic leukaemia (CLL) is a lymphoproliferative disorder resulting in functionally impaired lymphocytes, predisposing patients to various opportunistic infections. The author reports a recently treated patient with CLL presenting with constitutional symptoms accompanied by hepatosplenomegaly and diffuse adenopathy. Considering the recent diagnosis and treatment of CLL, initial suspicion was relapsed disease. However, considering the immune deficiency associated with CLL and its treatment, infectious aetiologies were strongly considered. Further investigation revealed a case of disseminated histoplasmosis mimicking CLL in this reported patient. Considering appropriate diagnosis and timely therapy, the reported patient had good prognosis despite being diagnosed with disseminated histoplasmosis. This case highlights consideration of disseminated histoplasmosis in patients presenting with diffuse adenopathy along with hepatomegaly and/or splenomegaly in the right clinical setting.
Subject(s)
Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Histoplasmosis/diagnosis , Itraconazole/therapeutic use , Leukemia, Lymphocytic, Chronic, B-Cell/immunology , Opportunistic Infections/diagnosis , Aged , Farmers , Fever , Hepatomegaly/microbiology , Histoplasmosis/drug therapy , Histoplasmosis/microbiology , Humans , Male , Opportunistic Infections/drug therapy , Opportunistic Infections/immunology , Radionuclide Imaging , Splenomegaly/microbiology , Tomography, X-Ray Computed , Treatment Outcome , Urinalysis , Weight LossABSTRACT
Listeriosis is a food borne illness of significant public health concern, caused by consumption of food contaminated by gram negative bacilli, Listeria monocytogenes. Clinical listeriosis is relatively rare and it has varying spectrum of presentation, ranging from severe sepsis in immune-compromised individuals, febrile gastroenteritis and meningo-encephalitis in infants and adults. This disease is under reported in developing nations due to the lack of awareness and inadequate laboratory facilities to promptly isolate and identify the organism. We report a case of sporadic food-borne listeriosis, in an otherwise healthy individual presenting with meningo-encephalitis. Prompt identification and appropriate antibiotic therapy led to a favorable outcome.
Subject(s)
Foodborne Diseases/microbiology , Listeria monocytogenes/isolation & purification , Listeriosis/diagnosis , Listeriosis/drug therapy , Meningoencephalitis/diagnosis , Ampicillin/therapeutic use , Anti-Bacterial Agents/therapeutic use , Foodborne Diseases/diagnosis , Foodborne Diseases/drug therapy , Gentamicins/therapeutic use , Hepatomegaly/microbiology , Humans , India , Listeriosis/transmission , Male , Meningoencephalitis/drug therapy , Meningoencephalitis/microbiology , Middle Aged , Splenomegaly/microbiologyABSTRACT
BACKGROUND: Disseminated cryptococcosis is a rare and fatal disease, and limited data exist regarding it in children. This study aimed to investigate the clinical characteristics of disseminated cryptococcosis in previously healthy children in China. METHODS: Hospitalized patients with disseminated cryptococcosis were enrolled during January 1996 to December 2015 in Beijing Children's Hospital, Capital Medical University, China. Data on clinical manifestations, laboratory tests, treatment, and prognosis were evaluated. RESULTS: A total of 52 pediatric patients with no underlying disease were enrolled, including 38 boys and 14 girls. Only 10 cases had a history of exposure to pigeon droppings. Fever, cough, and hepatomegaly were 3 main manifestations of disseminated cryptococcosis. However, headache was more common in patients with central nervous system (CNS) invasion than in patients with non-CNS invasion (P < 0.05). Lung (96.2%, 50/52) was the most commonly invaded organ, but only 9.6% (5/52) of patients had respiratory signs. The most common findings on chest imaging were hilar or mediastinal lymphadenopathy (46.8%, 22/47), and nodules (44.7%, 21/47), including small nodules in a scattered distribution (57.1%, 12/21) or miliary distribution (42.9%, 9/25), especially localized in subpleural area. Subsequent invasion occurred in the CNS, abdomen lymph nodes, liver, spleen, peripheral lymph nodes, and skin. In all patients, 42.3% (22/52) and 51.9% (27/52) had elevated eosinophils or IgE, respectively. The positive rate of serum cryptococcal antigen was higher, especially in patients with CNS invasion (approximately 83.3%), than with other primary methods used for pathogen detection, including cerebrospinal fluid (CSF) cryptococcal antigen, cultures of blood, bone marrow, or CSF, and CSF ink staining. The overall mortality rate of pediatric patients in our study was 11.5% (6/52). Some cases had long-term sequela, including hydrocephalus, cirrhosis, or blindness. CONCLUSIONS: Disseminated cryptococcosis can occur in previously healthy or immunocompetent children in China. Lung and CNS were most commonly invaded by this disease. Furthermore, most cases usually showed no obvious or specific symptoms or signs, and therefore pediatricians should pay more careful attention to identify this disease.
Subject(s)
Antifungal Agents/therapeutic use , Cryptococcosis/diagnosis , Cryptococcosis/etiology , Antigens, Fungal/blood , Child , Child, Preschool , China , Cough/microbiology , Cryptococcosis/drug therapy , Eosinophils/pathology , Female , Fever/microbiology , Headache/microbiology , Hepatomegaly/microbiology , Humans , Hydrocephalus/microbiology , Lung Diseases, Fungal/diagnosis , Lung Diseases, Fungal/microbiology , Lymph Nodes/pathology , Male , Prognosis , Radiography, Thoracic , Retrospective StudiesABSTRACT
Whipple's disease is a multisystemic infection with Tropheryma whipplei often characterised by its gastrointestinal involvement. However, due to the broad spectrum of unspecific symptoms, the diagnosis is often delayed. We report a case of a 70 year-old-man, who presented with extensive weight loss and lymphadenopathy. The diagnosis of Whipple's disease was made 18 months later on a duodenal biopsy. Retrospectively, it was discovered that a mesenterial biopsy taken earlier also revealed signs of Whipple's disease. Clinicians and pathologists need to be aware of this very rare and potentially fatal disease.
Subject(s)
Weight Loss , Whipple Disease/diagnosis , Aged , Anti-Bacterial Agents/therapeutic use , Ascites/microbiology , Constipation/microbiology , Diagnosis, Differential , Diarrhea/microbiology , Hepatomegaly/microbiology , Humans , Male , Tropheryma/isolation & purification , Whipple Disease/drug therapy , Whipple Disease/pathologyABSTRACT
OBJECTIVE: Abdominal tuberculosis (TB) is a relatively rare disease in most of Europe and the typical clinical and sonographic findings in this setting have not been studied. We aimed to define sonographic findings that should alert an examiner to the possibility of abdominal TB in a low endemic region. METHODS: Case records of 17 patients with proven (n = 11) or highly likely (n = 6) abdominal TB detected in the gastrointestinal ultrasound unit at a German tertiary care center in 2003-2013 were analyzed retrospectively. Findings were compared with reported series from high-prevalence regions. RESULTS: While 76% of patients had an immigrant background, only 35% had a condition associated with immunosuppression. Lymphadenopathy was present in all cases of abdominal TB, while it was absent in 28% of patients from a control group with proven abdominal sarcoidosis. Moreover, retroperitoneal lymphadenopathy was significantly more common in TB. Other findings in patients with abdominal TB in descending order of frequency were ascites, altered hepatic texture, splenomegaly, splenic lesions, peritoneal thickening, intestinal wall lesions, hepatic lesions and hepatomegaly. 76% of abdominal TB patients had 2 or more pathological findings. CONCLUSIONS: Multiple pathological intra-abdominal findings including lymphadenopathy should alert the examiner to the possibility of abdominal TB.
Subject(s)
Abdomen , Lymph Nodes/diagnostic imaging , Lymphatic Diseases/diagnostic imaging , Tuberculosis/diagnostic imaging , Adult , Aged , Ascites/microbiology , Emigration and Immigration , Female , Germany , Hepatomegaly/microbiology , Humans , Lymphatic Diseases/microbiology , Male , Mesentery , Middle Aged , Retroperitoneal Space , Retrospective Studies , Sarcoidosis/diagnostic imaging , Splenomegaly/microbiology , Tertiary Care Centers , Tuberculosis, Gastrointestinal/diagnostic imaging , Tuberculosis, Hepatic/diagnostic imaging , Tuberculosis, Splenic/diagnostic imaging , UltrasonographyABSTRACT
Isolated hepatic tuberculosis presenting as a mass either with or without fever can be confused with hepatocellular carcinoma. Clinical examination and laboratory investigations are not specific. Radiological investigations such as ultrasound and computed tomography cannot confirm the diagnosis; hence it is vital to always make an effort to demonstrate presence of acid fast bacilli in aspirated pus or necrotic material from a liver mass. We present a case of 50 years old male patient with HIV/AIDS who presented with non-specific symptoms without fever, clinically with hepatomegaly mimicking hepatocellular carcinoma with metastasis. Abdominal ultrasound revealed a mass in the left liver lobe, with diffuse involvement in the right liver lobe. Liver mass histology showed granulomatous pattern with epitheloid cell aggregation. Aspirated blood from fine-needle guided biopsy stained on Ziehl Neelsen for acid fast bacilli turned out positive. Clinical examination did not reveal lymphadenopathy, abdominal ultrasound also ruled out para-aortic lymphadenopathy, and chest x-ray was essentially normal. Evaluation of the patient six months after completing quadruple treatment for tuberculosis showed marked clinical improvement. The objective of this case report is to highlight the importance of considering hepatic tuberculosis as a differential diagnosis in cases of hepatomegaly and initiate appropriate investigations to rule out a possibility of Tuberculosis which is potentially treatable with early diagnosis.
Subject(s)
HIV Seropositivity , Liver Abscess/microbiology , Tuberculosis, Hepatic/diagnosis , Antitubercular Agents/therapeutic use , Biomarkers, Tumor/analysis , Carcinoma, Hepatocellular/diagnosis , Diagnosis, Differential , Hepatomegaly/diagnosis , Hepatomegaly/microbiology , Humans , Image-Guided Biopsy , Liver Neoplasms/diagnosis , Male , Middle Aged , Tomography, X-Ray Computed , Tuberculosis, Hepatic/drug therapyABSTRACT
The aim of this study was to analyse data relating to the liver function profile during acute infection from murine typhus in the city of Chania in the island of Crete (Greece). A retrospective study of the files of all the cases with a diagnosis of murine typhus admitted to the Saint George General Hospital of Chania over a 15-year period (1993-2008) was performed. Variations in alanine aminotransferase (ALT), aspartate aminotransferase (AST) and lactate dehydrogenase (LDH) levels were recorded from three consecutive examined serum samples. A total of 165 patients were diagnosed with murine typhus during the above time period. Serum aminotransferase and lactate dehydrogenase were abnormal in most of the first examined samples. Remarkably on admission, serum levels of AST, ALT, and LDH recorded an increase above the cut-off point in 142 (86%), 114 (69%) and 136 (82.4%) patients respectively. More than two out of every ten patients presented hepatomegaly. In conclusion, liver dysfunction occurs frequently in patients with murine typhus. A high level of physicians' awareness is required for the liver biochemical abnormalities caused by this worldwide zoonotic disease, especially in endemic areas such as Greece.
Subject(s)
Alanine Transaminase/blood , Aspartate Aminotransferases/blood , Endemic Diseases , Typhus, Endemic Flea-Borne/diagnosis , Typhus, Endemic Flea-Borne/epidemiology , Animals , Biomarkers/blood , Female , Greece/epidemiology , Hepatomegaly/microbiology , Hospitals, General , Humans , Immunoglobulin G/blood , Immunoglobulin M/blood , Liver Function Tests/methods , Male , Retrospective Studies , Typhus, Endemic Flea-Borne/blood , Typhus, Endemic Flea-Borne/microbiology , Typhus, Endemic Flea-Borne/transmissionABSTRACT
We report an unusual presentation of sacroiliitis and hepatitis secondary to Salmonella systemic infection. A high index of suspicion, early blood cultures, prompt investigations and treatment with parenteral antibiotics can result in complete resolution of symptoms and prevent long-term sequelae of either condition.
Subject(s)
Bacteremia/microbiology , Hepatitis/microbiology , Sacroiliitis/microbiology , Salmonella Infections/complications , Salmonella enteritidis , Adolescent , Anti-Bacterial Agents/therapeutic use , Bacteremia/drug therapy , Ceftriaxone/therapeutic use , Hepatitis/blood , Hepatitis/diagnosis , Hepatomegaly/diagnostic imaging , Hepatomegaly/microbiology , Humans , Liver Function Tests , Magnetic Resonance Imaging , Male , Sacroiliitis/diagnosis , Salmonella Infections/diagnosis , Salmonella Infections/drug therapy , Tomography, X-Ray ComputedABSTRACT
Streptococcus anginosus group is widely known for its ability to cause invasive pyogenic infections. There are very few reports of disseminated infections sustained by members of this streptococcal group. We report a case of a highly disseminated infection and analyse previous literature reports. Disseminated pyogenic infection has been defined as an infection affecting two or more of the following organs/systems: central nervous system, lung, liver and spleen. We performed a PubMed search using the terms: S. milleri, S. anginosus, brain abscess, pulmonary abscess, hepatic abscess, spleen abscess. We reviewed 12 case reports including the one presented in this paper. Underlying conditions such as dental infections, malignancy, gastrointestinal and respiratory tract disease accounted for 42% of cases. No definite endocarditis was encountered, even though positive blood cultures were found in 67% of patients. Concomitant brain-liver, brain-lung and brain-spleen involvement occurred in 50%, 42% and 8% of cases respectively. Ninety-one percent (91%) of patients were treated with ß-lactams, and surgical procedures were performed in 67% of patients. Infections caused by S. anginosus group members are satisfactorily treated with penicillin G and cephalosporins. It is very important to associate surgery to antimicrobial chemotherapy in order to achieve a full or nearly full clinical recovery.
Subject(s)
Anti-Bacterial Agents/therapeutic use , Bacteremia/microbiology , Streptococcal Infections/microbiology , Streptococcal Infections/therapy , Streptococcus anginosus , Suction , Bacteremia/diagnosis , Bacteremia/therapy , Brain Abscess/microbiology , Brain Abscess/therapy , Combined Modality Therapy , Empyema, Pleural/microbiology , Empyema, Pleural/therapy , Hepatomegaly/microbiology , Humans , Liver Abscess/microbiology , Liver Abscess/therapy , Lung Abscess/microbiology , Lung Abscess/therapy , Male , Middle Aged , Splenomegaly/microbiology , Streptococcal Infections/complications , Streptococcal Infections/diagnosis , Streptococcal Infections/drug therapy , Streptococcal Infections/surgery , Streptococcus anginosus/isolation & purification , Streptococcus anginosus/pathogenicity , Streptococcus milleri Group/isolation & purification , Streptococcus milleri Group/pathogenicity , Treatment OutcomeABSTRACT
The diagnosis of enteric fever poses several problems due to the non-specific and wide array of clinical features. A five-year retrospective study enrolling 136 culture-proven cases of enteric fever was undertaken in order to estimate the clinical and laboratory characteristics, fever clearance time and outcome. The common symptoms and signs were: fever, vomiting, cough, anorexia, diarrhoea, abdominal pain, hepatomegaly, splenomegaly and coated tongue. Enteric fever should be considered in the differential diagnosis of febrile patients with abdominal symptoms.
Subject(s)
Paratyphoid Fever/epidemiology , Salmonella paratyphi A/isolation & purification , Salmonella typhi/isolation & purification , Typhoid Fever/epidemiology , Adolescent , Child , Child, Preschool , Female , Hepatomegaly/diagnosis , Hepatomegaly/epidemiology , Hepatomegaly/microbiology , Humans , Incidence , India/epidemiology , Infant , Male , Paratyphoid Fever/diagnosis , Paratyphoid Fever/microbiology , Paratyphoid Fever/physiopathology , Splenomegaly/diagnosis , Splenomegaly/epidemiology , Splenomegaly/microbiology , Typhoid Fever/diagnosis , Typhoid Fever/microbiology , Typhoid Fever/physiopathologySubject(s)
Abdominal Pain/etiology , Antibodies, Bacterial/blood , Bartonella Infections/diagnosis , Bartonella henselae/immunology , Fever of Unknown Origin/etiology , Acute-Phase Proteins/analysis , Animals , Bartonella Infections/complications , Bartonella Infections/diagnostic imaging , Bartonella Infections/pathology , Bartonella Infections/transmission , Cats/microbiology , Child , Hepatomegaly/diagnostic imaging , Hepatomegaly/etiology , Hepatomegaly/microbiology , Hepatomegaly/pathology , Humans , Magnetic Resonance Imaging , Male , Spleen/diagnostic imaging , Spleen/microbiology , Spleen/pathology , Ultrasonography , ZoonosesABSTRACT
OBJECTIVES: To determine risk factors in children for the acquisition of Brucella, clinical presentation, treatment, and disease outcomes. METHODS: A retrospective multicenter chart review was undertaken of children identified with brucellosis from 1986 to 2008 at three tertiary care centers in Chicago, Illinois, USA. The charts were reviewed for data regarding risk factors for acquisition, clinical presentation, and outcomes. RESULTS: Twenty-one charts were available for review. The median age was 6.5 years (range 2-14 years); 62% were female. Ethnic background was 67% Hispanic and 24% Arabic. Risk factors included travel to an endemic area (86%), particularly Mexico, and consumption of unpasteurized milk products (76%). Common findings included fever (95%), bacteremia (86%), elevated liver transaminases (80%), constitutional symptoms (76%), splenomegaly (60%), and hepatomegaly (55%). Relapse occurred in three of six subjects started on single drug treatment, but in only one of 15 subjects who started on two or more drugs (p=0.053). No relapses occurred in children whose initial therapy included rifampin or those administered three-drug regimens. CONCLUSIONS: Brucella is an infrequent pathogen but should be considered in children with compatible epidemiologic and clinical characteristics. Blood cultures should be obtained, and initial therapy with two or more drugs may decrease the risk of relapse.
Subject(s)
Anti-Bacterial Agents/therapeutic use , Bacteremia/epidemiology , Brucella/isolation & purification , Brucellosis/epidemiology , Adolescent , Animals , Bacteremia/diagnosis , Bacteremia/drug therapy , Bacteremia/microbiology , Brucella/drug effects , Brucellosis/diagnosis , Brucellosis/drug therapy , Brucellosis/microbiology , Chicago/epidemiology , Child , Child, Preschool , Drug Therapy, Combination , Female , Hepatomegaly/microbiology , Humans , Male , Mexico , Milk/microbiology , Recurrence , Retrospective Studies , Risk Factors , Splenomegaly/microbiology , TravelABSTRACT
Previously, we demonstrated unique protein expression patterns in 20-week-Schistosoma mansoni-infected CBA/J mice with moderate splenomegaly syndrome (MSS) or hypersplemomegaly syndrome (HSS). To better understand the development of severe pathology, we compared the two-dimensional differential in-gel electrophoresis (2D-DIGE) proteomic signatures of livers from uninfected mice and mice infected for 6, 8, 12, or 20 weeks and found significant changes in collagen isoforms, interleukin-2 (IL-2), cytokeratin 18, hydroxyproline, S. mansoni phosphoenolpyruvate carboxykinase, major urinary protein isoforms, and peroxiredoxin 6. Cytokeratin 18, hydroxyproline, and connective tissue growth factor (CTGF) were chosen for analysis in mouse and human sera using targeted biochemical assays. Consistent with the liver analysis, cytokeratin 18, CTGF, and hydroxyproline were significantly elevated in sera from mice with HSS compared to those from uninfected mice or mice with MSS. Moreover, cytokeratin 18 and CTGF were found to be markers for subjects with hepatosplenic and intestinal schistosomiasis, respectively, while serum hydroxyproline was a strong indicator of fibrosis for severe HS. These findings indicate that schistosome-associated changes to the liver can be detected in the serum and reveal the potential for cytokeratin 18 to be used as a diagnostic marker for early detection of hepatosplenic schistosomiasis.
Subject(s)
Biomarkers/analysis , Keratin-18/analysis , Liver Diseases, Parasitic/diagnosis , Schistosomiasis/diagnosis , Splenomegaly/diagnosis , Animals , Blotting, Western , Electrophoresis, Gel, Two-Dimensional , Hepatomegaly/diagnosis , Hepatomegaly/metabolism , Hepatomegaly/microbiology , Humans , Keratin-18/biosynthesis , Liver Diseases, Parasitic/metabolism , Male , Mass Spectrometry , Mice , Mice, Inbred CBA , Schistosomiasis/complications , Schistosomiasis/metabolism , Splenomegaly/metabolism , Splenomegaly/microbiologySubject(s)
Autistic Disorder/complications , Behcet Syndrome/diagnosis , Fever/microbiology , Hepatomegaly/microbiology , Histoplasmosis/diagnosis , Oral Ulcer/etiology , Splenomegaly/microbiology , Vision Disorders/etiology , Vitamin A Deficiency/diagnosis , Adolescent , Behcet Syndrome/drug therapy , Diagnosis, Differential , Feeding and Eating Disorders of Childhood/etiology , Female , Histoplasmosis/drug therapy , Humans , Infant , Male , Recurrence , Treatment Outcome , Vision Disorders/complications , Vision Disorders/therapy , Vitamin A Deficiency/complications , Vitamin A Deficiency/therapyABSTRACT
A 6-hour-old infant was admitted with severe respiratory distress and hepatosplenomegaly. Her mother had arthralgia for 4 weeks in the 7/8th month of pregnancy and the infant was born at 31 weeks. Brucella spp was detected in blood culture and serology in mother and infant, supporting the diagnosis of brucellosis with presumed transplacental transmission.